Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-blind Parallel-group Study of TS-091 (enerisant) in Narcolepsy
jRCT2080223633Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Aug 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in narcolepsy comparing TS-091 (enerisant) with Placebo (2 arms). Started Aug 2017; status: completed.
02
Drugs
Enerisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on jRCT2080223633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223633.